Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
- PMID: 23446880
- PMCID: PMC3669650
- DOI: 10.1007/s00520-013-1766-y
Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study
Abstract
Purpose: This study was conducted in order to characterize the prevalence of falls and functional impairments (FIs) and their association with chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
Methods: We analyzed baseline assessments from a phase III RCT in cancer survivors with self-reported CIPN scores of >4 out of 10. Patients completed the EORTC QLQ-CIPN-20 for neuropathy and reported falls in the previous 3 months. FIs were defined using the Activities of Daily Living subsection of the Vulnerable Elder's Scale. Associations of baseline characteristics and CIPN with falls and FIs were examined using logistic regression.
Results: Of 421 patients, 11.9 % experienced recent falls and 26.6 % reported FIs. Motor neuropathy was the only factor associated with falls (OR = 1.127, p = 0.01). Factors associated with FIs included non-white race (OR = 0.335 white relative to non-white, 0.781, p = 0.01) and greater motor neuropathy scores (OR = 1.262, p < 0.0001).
Conclusion: CIPN, primarily motor, is associated with falls and FIs. Future prospective research should investigate the ability of motor neuropathy severity to predict falls.
Conflict of interest statement
Figures
Similar articles
-
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.Breast Cancer Res Treat. 2016 Sep;159(2):327-33. doi: 10.1007/s10549-016-3939-0. Epub 2016 Aug 10. Breast Cancer Res Treat. 2016. PMID: 27510185 Free PMC article.
-
Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.J Clin Oncol. 2017 Aug 10;35(23):2604-2612. doi: 10.1200/JCO.2016.71.3552. Epub 2017 Jun 6. J Clin Oncol. 2017. PMID: 28586243 Free PMC article.
-
Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy.Asia Pac J Oncol Nurs. 2019 Jul-Sep;6(3):253-260. doi: 10.4103/apjon.apjon_7_19. Asia Pac J Oncol Nurs. 2019. PMID: 31259221 Free PMC article.
-
Chemotherapy-Induced Peripheral Neuropathy: Association With Increased Risk of Falls and Injuries.Clin J Oncol Nurs. 2019 Aug 1;23(4):405-410. doi: 10.1188/19.CJON.405-410. Clin J Oncol Nurs. 2019. PMID: 31322611 Review.
-
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733808 Review.
Cited by
-
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.JAMA Neurol. 2016 Jul 1;73(7):860-6. doi: 10.1001/jamaneurol.2016.0383. JAMA Neurol. 2016. PMID: 27183099 Free PMC article.
-
Endoplasmic Reticulum Stress in Chemotherapy-Induced Peripheral Neuropathy: Emerging Role of Phytochemicals.Antioxidants (Basel). 2022 Jan 28;11(2):265. doi: 10.3390/antiox11020265. Antioxidants (Basel). 2022. PMID: 35204148 Free PMC article. Review.
-
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).Breast Cancer Res. 2018 Nov 28;20(1):146. doi: 10.1186/s13058-018-1077-9. Breast Cancer Res. 2018. PMID: 30486865 Free PMC article.
-
The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.Curr Oncol Rep. 2020 Apr 22;22(5):50. doi: 10.1007/s11912-020-00903-0. Curr Oncol Rep. 2020. PMID: 32323068 Review.
-
Supportive Care in Older Adults with Cancer: Across the Continuum.Curr Oncol Rep. 2016 Aug;18(8):51. doi: 10.1007/s11912-016-0535-8. Curr Oncol Rep. 2016. PMID: 27342609 Free PMC article. Review.
References
-
- Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer. 2004;12(9):619–625. - PubMed
-
- Argyriou AA, Koltzenburg M, Polychronopoulos P, Papapetropoulos S, Kalofonos HP. Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol. 2008;66(3):218–228. - PubMed
-
- Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain. 2004;109(1–2):132–142. - PubMed
-
- Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9–17. - PubMed
-
- Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27–46. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical